- Moneycontrol /
- Market /
- Pharmaceuticals /
- HALF YEARLY RESULTS
BSE Live
Aug 06, 16:00Prev. Close
4421.95
Open Price
4430.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Aug 06, 15:59Prev. Close
4424.85
Open Price
4450.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4389.95 (139)
| Half Yearly Results of Pfizer (in Rs. Cr.) | Mar '20 | Sep '19 | Mar '19 | Sep '18 | Mar '18 | |
| Net Sales/Income from operations | 1,040.19 | 1,111.46 | 1,049.45 | 1,032.05 | 976.49 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 1,040.19 | 1,111.46 | 1,049.45 | 1,032.05 | 976.49 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 195.06 | 150.15 | 176.22 | 167.43 | 164.53 | |
| Purchase of Traded Goods | 302.21 | 181.60 | 299.72 | 195.41 | 216.67 | |
| Increase/Decrease in Stocks | -105.32 | 68.70 | -115.37 | 24.49 | -23.71 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 190.63 | 173.88 | 165.16 | 158.68 | 154.22 | |
| Depreciation | 53.11 | 50.13 | 35.38 | 36.01 | 35.00 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 215.46 | 206.72 | 218.40 | 226.16 | 208.39 | |
| P/L Before Other | 189.04 | 280.28 | 269.94 | 223.87 | 221.39 | |
| Other Income | 103.44 | 80.58 | 99.80 | 67.59 | 63.31 | |
| P/L Before Int. | 292.48 | 360.86 | 369.74 | 291.46 | 284.70 | |
| Interest | 6.08 | 4.77 | 0.90 | 0.39 | 0.08 | |
| P/L Before Exceptional Items & Tax | 286.40 | 356.09 | 368.84 | 291.07 | 284.62 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 286.40 | 356.09 | 368.84 | 291.07 | 284.62 | |
| Tax | 44.33 | 89.03 | 127.43 | 103.43 | 92.87 | |
| P/L After Tax from Ordinary Activities | 242.07 | 267.06 | 241.41 | 187.64 | 191.75 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 242.07 | 267.06 | 241.41 | 187.64 | 191.75 | |
| Equity Share Capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 52.91 | 58.38 | -- | 41.01 | -- | |
| Diluted EPS | -- | 58.38 | -- | 41.01 | -- | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 52.91 | 58.38 | -- | 41.01 | -- | |
| Diluted EPS. | -- | 58.38 | -- | 41.01 | -- | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
19.10.2016
05.08.2016
03.01.2014
10.01.2011
